Senores Pharmaceuticals Ltd's material subsidiary reeceives 3 observations from USFDA for its facility

Havix Group Inc. D/B/A Aavis Pharmaceuticals ("Havix"), a Material Subsidiary of Senores Pharmaceuticals Ltd situated at 9488 Jackson Trail Road, Hoschton, Georgia 30548, USA has completed the United States Food & Drug Administration ("USFDA") inspection of its manufacturing facility from July 21, 2025 to July 25, 2025 with 3 (Three), 483 observations.

These observations are procedural and minor in nature and Havix will respond to these observations within 15 days.

Shares of Senores Pharmaceuticals Limited was last trading in BSE at Rs. 642.95 as compared to the previous close of Rs. 668.10. The total number of shares traded during the day was 40875 in over 2158 trades.

The stock hit an intraday high of Rs. 679.10 and intraday low of 631.00. The net turnover during the day was Rs. 26758624.00.

Source : Equity Bulls

Keywords

SenoresPharmaceuticals SENORES INE0RB801010 HavixGroupInc USFDA 3Observations